1. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma
   Jian Wang et al, 2020, Biomolecules CrossRef
2. Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
   Annalisa Chianese et al, 2021, Cancers CrossRef
3. Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein
   Yousef Douzandegan et al, 2019, Osong Public Health and Research Perspectives CrossRef
4. Stability and Hopf Bifurcation Analysis of an Oncolytic Virus Infection Model with Two Time Delays and Saturation Incidence
   Xia Liu et al, 2022, Mathematical Problems in Engineering CrossRef
5. Role of mucoadhesive agent in ocular delivery of ganciclovir microemulsion: cytotoxicity evaluation in vitro and ex vivo
   Manisha Choudhari et al, 2022, International Ophthalmology CrossRef
6. The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
   Mohammed A Zolaly et al, 2023, Cureus CrossRef
7. Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
   Mariangela Garofalo et al, 2021, Pharmaceutics CrossRef
8. Artificial Life and Therapeutic Vaccines Against Cancers that Originate in Viruses
   María Elena Escobar-Ospina et al, 2019, Global Virology III: Virology in the 21st Century CrossRef
9. The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
   Dmitriy A Morozov et al, 2019, Journal of Modern Oncology CrossRef
10. Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer
    Ofek Mussafi et al, 2022, Frontiers in Oncology CrossRef
11. Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
    Anne Everts et al, 2020, Biomedicines CrossRef